Immunome Inc. financial data

Symbol
IMNM on Nasdaq
Industry
Pharmaceutical Preparations
Location
18702 N. Creek Parkway, Suite 100, Bothell, WA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 646 % +92.9%
Debt-to-equity 19 % -84.4%
Return On Equity -125 % +56.3%
Return On Assets -105 % +18.4%
Operating Margin -3.38K % -333%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87M shares +45.7%
Common Stock, Shares, Outstanding 64.5M shares +49%
Entity Public Float 643M USD +751%
Common Stock, Value, Issued 6K USD +50%
Weighted Average Number of Shares Outstanding, Basic 58.6M shares +196%
Weighted Average Number of Shares Outstanding, Diluted 58.6M shares +196%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.04M USD -35.5%
Research and Development Expense 130M USD +461%
General and Administrative Expense 33M USD +67.7%
Operating Income (Loss) -306M USD -179%
Net Income (Loss) Attributable to Parent -293M USD -174%
Earnings Per Share, Basic -5 USD/shares +7.06%
Earnings Per Share, Diluted -5 USD/shares +7.06%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 143M USD +45.3%
Assets, Current 221M USD +53%
Property, Plant and Equipment, Net 10.1M USD +388%
Operating Lease, Right-of-Use Asset 4.28M USD +174%
Other Assets, Noncurrent 4.41M USD +4311%
Assets 240M USD +61.7%
Accounts Payable, Current 14.2M USD +329%
Employee-related Liabilities, Current 5.22M USD +91%
Contract with Customer, Liability, Current 6.94M USD -33.9%
Liabilities, Current 54.3M USD +149%
Contract with Customer, Liability, Noncurrent 2.21M USD -76.6%
Deferred Income Tax Liabilities, Net 1.03M USD +173%
Operating Lease, Liability, Noncurrent 4.77M USD +256%
Other Liabilities, Noncurrent 1.34M USD +2061%
Liabilities 59.1M USD +106%
Accumulated Other Comprehensive Income (Loss), Net of Tax 57K USD +159%
Retained Earnings (Accumulated Deficit) -516M USD -131%
Stockholders' Equity Attributable to Parent 181M USD +51.1%
Liabilities and Equity 240M USD +61.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.2M USD -146%
Net Cash Provided by (Used in) Financing Activities 219M USD +645326%
Net Cash Provided by (Used in) Investing Activities -37.2M USD -35024%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 64.5M shares +49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 171M USD +610%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 143M USD +45.2%
Deferred Tax Assets, Valuation Allowance 107M USD +168%
Deferred Tax Assets, Gross 108M USD +168%
Operating Lease, Liability 4.83M USD
Payments to Acquire Property, Plant, and Equipment 2.16M USD +1942%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -293M USD -174%
Lessee, Operating Lease, Liability, to be Paid 12.8M USD
Operating Lease, Liability, Current 63K USD -79.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.3M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 929K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.2M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.58M USD
Deferred Tax Assets, Operating Loss Carryforwards 29.3M USD +28.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 56K USD +51.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.62M USD
Additional Paid in Capital 697M USD +103%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 157K USD +67%
Deferred Tax Assets, Net of Valuation Allowance 1.03M USD +173%
Share-based Payment Arrangement, Expense 15.7M USD +153%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%